Results

1–10 of 352 results for diabetic

Faricimab Response is Associated With Intraocular Pressure Lowering in Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
Tamara L Lenis, MD, PhD
Annual Meeting Talks
2024
Silicone Oil Droplets in the Vitreous After Intravitreal Injection With a Silicone Oil-Free and a Siliconized Insulin Syringe: A Randomized Clinical Trial
Gustavo Barreto de Melo, MD, PhD, FASRS
Annual Meeting Talks
2024
The Effect of Lens Status on the Rate of Postoperative Hemorrhage and Complications in Diabetic Vitrectomies
Santi S Karnam, MD
Annual Meeting Talks
2024
Long-Term Outcome of Diabetic Eyes With Vitreous Hemorrhage in an Urban Safety-Net Hospital
Hossein Ameri, MD, PhD, FRCSI, MRCOphth
Annual Meeting Talks
2024
Intraoperative Fluorescein Angiography Reduces the Rate of Postoperative Vitreous Hemorrhage
Alan J. Franklin, MD, PhD
Annual Meeting Talks
2024
Dropless Vitrectomy Surgery for Dense Vitreous Hemorrhage Secondary to Proliferative Diabetic Retinopathy; Efficacy and Safety Compared With Standard of Care
K. V. Chalam, MD, PhD, MBA, FRCS(C), FASRS
Annual Meeting Talks
2024
Durability of Combination Therapy of Sozinibercept, an Anti-VEGF-C/D 'Trap' With Ranibizumab in nAMD or Aflibercept in DME
Nathan C. Steinle, MD
Annual Meeting Talks
2024
Diabetic Retinopathy Lesion Types and Distribution on Ultra-Widefield Imaging and the Risk for Disease Worsening Over Time
Paolo Antonio S. Silva, MD
Annual Meeting Talks
2024
Optimizing Oral Fluorescein Angiography: A Comparative Study Evaluating Concentrations and Efficacy in Retinal Imaging
Guillermo Salcedo-Villanueva, MD
Annual Meeting Talks
2024
A Randomized Trial Comparing Suprachoroidal Injection of Triamcinolone and Intravitreal Dexamethasone Implant for Refractory Diabetic Macular Edema
Murat Oncel, MD, FASRS
Annual Meeting Talks
2024